
The manufacturer of the only monkeypox vaccine approved by the Food and Drug Administration has written to federal health officials warning against a plan to split doses to stretch the supply.
In a letter sent to Health and Human Services Secretary Xavier Becerra, and Food and Drug Administration Commissioner Robert M Califf, Bavarian Nordic CEO Paul Chaplin wrote: “We do have some reservations … due to the very limited safety data available.”